- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06765070
Efficacité et convivialité de l'exosquelette EXPLORER chez les enfants atteints de troubles neurodéveloppementaux en milieu naturel
Efficacité et convivialité de l'exosquelette EXPLORER chez les enfants atteints de troubles neurodéveloppementaux dans leur environnement naturel
Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. EXPLORER is a robotic gait exoskeleton designed to rehabilitate children with motor disabilities in home and outdoor environments.
The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. Robotic devices are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER is a robotic device designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.
An initial session will be conducted in the participant's natural environment, during which the researchers will instruct the primary caregivers on the use of the device. Subsequently, the device will be left for a two-month period for use in the natural settings deemed appropriate by the family.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Madrid
-
Alcorcón, Madrid, Espagne, 28922
- Universidad Rey Juan Carlos
-
Madrid, Madrid, Espagne, 28046
- Hospital Universitario La Paz
-
Madrid, Madrid, Espagne, 28009
- Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia
-
Madrid, Madrid, Espagne, 28007
- Hospital Universitario Gregorio Marañón
-
Madrid, Madrid, Espagne, 28009
- Hospital Infantil Universitario Niño Jesús - Servicio de Rehabilitación
-
Madrid, Madrid, Espagne, 28041
- Hospital Universitario 12 Octubre
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Diagnosis of any pathology or condition causing neurodevelopmental disorders.
- Ability to continuously use the device for two weeks, at least 3 times per week, without causing excessive fatigue that would prevent the participant from carrying out their usual activities.
- Availability and commitment from the family to use the device at least 3 times per week during the planned period, in different environments and with various objectives.
- Medical authorization for standing, gait training and weight bearing.
- Informed consent signed by legal guardians.
- Maximum user weight of 60 kg.
- Hip width (between greater trochanters) ≤37 cm.
- Length of the thigh (distance from the greater trochanter to the lateral condyle of the tibia) from 21cm to 36cm.
- Tibia leg length (distance from the lateral condyle of the tibia to the lateral malleolus) from 20cm to 35cm.
- Shoe size ≤40 (EU)
Exclusion Criteria:
- Medical contraindications for standing or walking.
- Non-reducible contractures or heterotropic ossifications above the degrees allowed by the device or out of the trajectory imposed by the device
- Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of the device.
- More than 20º of hip and/or knee non-reducible contractures at the time of using the exoskeleton.
- Necessity to walk with more than 5º of hip abduction.
- Impossibility to reach 5º of ankle dorsiflexion with ir without orthoses.
- Lower length dysmetria that cannot be mitigated with a wedge under the foot.
- Skin lesion on parts of the lower extremities that are in contact with the device.
- History of fracture without trauma.
- Presence of other conditions causing exercise intolerance (such as uncontrolled hypertension, coronary artery disease, arrhythmia, congestive heart failure, severe pulmonary disease).
- Conductual disorders that may interfere with the use of the device or their participation in the study, like impulsiveness.
- Allergy to any of the EXPLORER materials: cotton, nylon, polyester, PPS, PEEK or ABS.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: EXPLORER
Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family. |
Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Serious Adverse Events
Délai: through study completion, along 2 weeks
|
occurrence of any serious adverse event to the participant or the caregiver |
through study completion, along 2 weeks
|
|
Falls prevalence
Délai: through study completion, along 2 weeks
|
Number of falling events occurred from the participant or caregiver |
through study completion, along 2 weeks
|
|
Skin integrity
Délai: through study completion, along 2 weeks
|
Occurrence of any injury of the skin in the areas of contact and produced by the use of the device |
through study completion, along 2 weeks
|
|
Pain (Visual Analogic Scale)
Délai: through study completion, along 2 weeks
|
pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver, scored from 0 to 10, being 0 "no pain" and 10 "unbearable pain" |
through study completion, along 2 weeks
|
|
Donning and doffing time
Délai: through study completion, along 2 weeks
|
Time to don and doff the device to each participant |
through study completion, along 2 weeks
|
|
Device usage time
Délai: through study completion, along 2 weeks
|
Time using the device |
through study completion, along 2 weeks
|
|
Number of steps
Délai: through study completion, along 2 weeks
|
number of steps with the device |
through study completion, along 2 weeks
|
|
Usage modes
Délai: through study completion, along 2 weeks
|
two different usage modes (active and automatic). |
through study completion, along 2 weeks
|
|
Speed
Délai: through study completion, along 2 weeks
|
speed achieved with the device (steps per minute) |
through study completion, along 2 weeks
|
|
Device accessibility
Délai: through study completion, along 2 weeks
|
Environments where the device has been used and level of accessibility in each environment measured with a 5 points Likert scale (0 not accessible - 5 very accessible) |
through study completion, along 2 weeks
|
|
Range of motion
Délai: Before starting the intervention (S1) and after completing the two weeks of use
|
Passive Degree to which a joint can move (hip, knee, and ankle joints in both legs). From 0º to 180º. |
Before starting the intervention (S1) and after completing the two weeks of use
|
|
Participation
Délai: Before starting the intervention (S1) and after completing the two weeks of use
|
Measured with the Child and Adolescent Scale of Participation. 20 ordinal scaled items across 4 subsections. Maximum total score is 80 (20 items x 4) and the minimum total score is 20 (20 items x 1) |
Before starting the intervention (S1) and after completing the two weeks of use
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
QUEST
Délai: at the end of the intervention
|
Using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire administered to the participants' caregivers at the end of the intervention. The QUEST 2.0 scale has 12 items. Each item is rated on a 5-point Likert scale |
at the end of the intervention
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Les troubles mentaux
- Blessures et Blessures
- Maladies neurodégénératives
- Traumatisme crânio-cérébral
- Traumatisme, système nerveux
- Lésions cérébrales chroniques
- Maladies de la moelle épinière
- Maladie du motoneurone
- Troubles neurodéveloppementaux
- Lésions cérébrales
- Paralysie cérébrale
- Blessures à la moelle épinière
- Atrophie musculaire, spinale
- Maladies neuromusculaires
Autres numéros d'identification d'étude
- EXP-I-EF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .